A comparison of trends in melanoma mortality in New Zealand and Australia: The two countries with the highest melanoma incidence and mortality in the world

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Sneyd, Mary Jane ^a   Cox, Brian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Melanoma; Mortality; Trends

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEW ZEALAND; TREND STUDY; FOLLOW UP; INCIDENCE; MIDDLE AGED; MORTALITY; PROGNOSIS; SUNLIGHT; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MORTALITY; NEW ZEALAND; PROGNOSIS; SUNLIGHT; SURVIVAL RATE; YOUNG ADULT;

EID: 84881048078     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-372     Document Type: Article

References (39)

1. International Agency for Research on Cancer WHO cancer mortality database IARC, http://www-dep.iarc.fr/WHOdb/WHOdb.htm, International Agency for Research on Cancer.
2. New Zealand Health Information Service Cancer: new registratons and deaths, 2007 2010, Wellington: Ministry of Health, New Zealand Health Information Service.
3. Australian Institute of Health and Welfare Australian cancer incidence and mortality (ACIM) books [http://www.aihw.gov.au/acim-books/], Australian Institute of Health and Welfare.
4. Lemus-Deschamps L, Rikus L, Grainger S, Gies P, Sisson J, Li Z. UV index and UV dose distributions for Australia (1997-2001). Australian Metereological Magazine 2004, 53:239-250.
5. Stracci F, Minelli L, D'Alo D, Fusco-Moffa I, Falsettini E, Cassetti T, Romagnoli C, La Rosa F. Incidence, mortality and survival trends of cutaneous melanoma in Umbria, Italy, 1978-82 and 1994-98. Tumori 2005, 91:6-8.
6. Montague M, Borland R, Sinclair C. Slip! slop! slap! and SunSmart, 1980-2000: skin cancer control and 20 years of population-based campaigning. Health Education & Behaviour 2001, 28(3):290-305. 10.1177/109019810102800304, 23930245.
7. Coory M, Baade P, Aitken J, Smithers M, Roderick G, McLeod C, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006, 17:21-27. 10.1007/s10552-005-3637-4, 16411049.
8. Garvin T, Eyles J. Public health responses for skin cancer prevention: the policy framing of sun safety in Australia, Canada and England. Soc Sci Med 2001, 53:1175-1189. 10.1016/S0277-9536(00)00418-4, 11556608.
9. Watts C, Reeder A, Glasgow H. A cover-up story: the cancer society melanoma prevention programme. UV radiation and Its effects - An update 2002 2002, 1-3. Christchurch: Royal Society of New Zealand, McKenzie R, Reisinger A, Watts C.
10. Cooke K, Skegg D, Fraser J. Trends in malignant melanoma of skin in New Zealand. Int J Cancer 1983, 31:715-718. 10.1002/ijc.2910310607, 6862682.
11. Holman C, James I, Gattey P, Armstrong B. An analysis of trends in mortality from malignant melanoma of the skin in Australia. Int J Cancer 1980, 26:703-709. 10.1002/ijc.2910260602, 7216539.
12. Severi G, Giles G, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000, 82(11):1887-1891. 10.1054/bjoc.1999.1243, 2363233, 10839308.
13. Montella A, Gavin A, Middleton R, Autier P, Boniol M. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer 2009, 45:2360-2366. 10.1016/j.ejca.2009.03.004, 19375307.
14. New Zealand Health Information Service Cancer: new registrations and deaths 2000 2004, Wellington: Ministry of Health, New Zealand Health Information Service.
15. New Zealand Health Information Service Mortality and demographic data 2000 2004, 1-144. Wellington: Ministry of Health, New Zealand Health Information Service.
16. Australian Institute of Health and Welfare Collection of mortality data [http://www.aihw.gov.au/collection-of-mortality-data/], Australian Institute of Health and Welfare.
17. Doll R. Comparison between registries: age-standardized rates. Cancer Incidence in Five Continents Vol III 1976, Lyon, France: International Agency for Research on Cancer, Waterhouse J, Muir C, Correa P, Powell J.
18. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. Am Stat Assoc J 1963, 58:690-700.
19. Case RAC. Cohort analysis of mortality rates as an historical or narrative technique. Br J Prev Soc Med 1956, 10(4):159-171. 1058639, 13396199.
20. Australian Bureau of Statistics Cause of death certification Australia, 2008 2008, Canberra: Australian Bureau of Statistics, Australian Bureau of Statistics.
21. New Zealand Health Information Service A guide to certifying causes of death 2001, Wellington: Ministry of Health, New Zealand Health Information Service.
22. Cooke K. Melanoma mortality in middle-aged and older men, and older women in New Zealand. Cancer Detect Prev 1996, 20(3):245-250.
23. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health 2005, 29(4):383-386. 10.1111/j.1467-842X.2005.tb00211.x, 16222938.
24. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous melanoma in Europe. Has the epidemic levelled off?. Melanoma Res 2004, 14:301-309. 10.1097/01.cmr.0000136710.75287.1c, 15305162.
25. Lasithiotakis K, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, Strobel W, Garbe C. The incidence and mortality of cutaneous melanoma in Southern Germany. Cancer 2006, 107:1331-1339. 10.1002/cncr.22126, 16909413.
26. Downing A, Newton Bishop J, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer 2006, 95:91-95. 10.1038/sj.bjc.6603216, 2360483, 16755289.
27. Cayuela A, Rodriguez-Dominguez S, Vigil E, Conejo-Mir J. Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004. Int J Cancer 2008, 122:905-908. 10.1002/ijc.23118, 17957799.
28. Mackie R, Bray C, Vestey J, Doherty V, Evans A, Thomson D, Nicolson M, for the Scottish Melanoma Group Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 2007, 96:1772-1777. 10.1038/sj.bjc.6603801, 2359933, 17533392, for the Scottish Melanoma Group.
29. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236. 10.3322/caac.20121, 21685461.
30. Sneyd M, Cox B. Clinical and histologic factors associated with melanoma thickness in New Zealand Europeans, Maori, and Pacific peoples. Cancer 2011, 117(11):2489-2498.
31. Geller A, Swetter S, Brooks K, Demierre M, Yaroch A. Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. J Am Acad Dermatol 2007, 57(4):555-572. 10.1016/j.jaad.2007.06.032, 17870429.
32. Sneyd M. Malignant melanoma: early diagnosis and screening. PhD thesis 1999, Dunedin: University of Otago.
33. McPherson M, Elwood M, English D, Baade P, Youl P, Aitken J. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 2006, 54(5):783-792. 10.1016/j.jaad.2005.08.065, 16635658.
34. Baade P, Meng X, Youlden D, Aitken J, Youl P. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006. Int J Cancer 2012, 130:170-178. 10.1002/ijc.25996, 21344376.
35. Baumert J, Plewig G, Volkenandt M. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007, 156(5):938-944. 10.1111/j.1365-2133.2007.07805.x, 17381454.
36. Richard M, Grob J, Avril M, Delaunay M, Thirion X, Wolkenstein P, Souteyrand P, Dreno B, Bonerandi J, Dalac S, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 1999, 135(3):269-274. 10.1001/archderm.135.3.269, 10086447.
37. Richard M, Grob J, Avril M, Delaunay M, Gouvernet J, Wolkenstein P, Souteyrand P, Dreno B, Bonerandi J, Dalac S, et al. Delays in diagnosis and melanoma prognosis (II); the role of doctors. Int J Cancer 2000, 89(3):280-285. 10.1002/1097-0215(20000520)89:3<280::AID-IJC11>3.0.CO;2-2, 10861505.
38. Richard M, Grob J, Avril M, Delaunay M, Gouvernet J, Wolkenstein P, Souteyrand P, Dreno B, Bonerandi J, Dalac S, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000, 89(3):271-279. 10.1002/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7, 10861504.
39. Geller A, Elwood M, Swetter S, Brooks D, Aitken J, Youl P, Demierre M, Baade P. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer 2009, 115:1318-1327. 10.1002/cncr.24162, 19189368.